MiR-132 Serves As a Diagnostic Biomarker in Gestational Diabetes Mellitus and Its Regulatory Effect on Trophoblast Cell Viability

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2019 Oct 27

PMID 31653266

Citations 28

Authors

Xuegui Zhou

Cuiping Xiang

Xiaoxia Zheng

Affiliations

Soon will be listed here.

Abstract

Background: Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes. Strategies that improve trophoblast cell function are important methods for GDM treatment. This study aimed to investigate the expression and diagnostic potential of microRNA-132 (miR-132) in GDM patients, and further analyzed the effects of miR-132 on HTR-8/SVneo cell proliferation.

Methods: Quantitative real-time PCR was applied to estimate the expression of miR-132. A receiver operating characteristics curve (ROC) analysis was performed to evaluate the diagnostic value of serum miR-132 in GDM patients. In vitro regulation of miR-132 in trophoblast cell HTR-8/SVneo was achieved by cell transfection, and the effects of miR-132 on cell proliferation were assessed using CCK-8 assay.

Results: Expression of miR-132 was decreased in serum and placenta tissues in GDM patients compared with the healthy women. A negative correlation was found between the serum miR-132 levels and fasting blood glucose of the GDM patients. A ROC curve shown the serum miR-132 had considerable diagnostic accuracy with an area under the curve (AUC) of 0.898. High glucose (HG) treatment induced an inhibition in HTR-8/SVneo cell proliferation and the expression of miR-132. The overexpression of miR-132 in HTR-8/SVneo cells could markedly rescued the HG - induced suppressed cell proliferation.

Conclusion: All the data of this study revealed the reduced expression of miR-132 in serum and placenta tissues of GDM, and serum miR-132 serves a candidate biomarker in the diagnosis of GDM. miR-132 may act a protective role against GDM via enhancing the trophoblast cell proliferation.

Citing Articles

Cohort-specific boolean models highlight different regulatory modules during Parkinson's disease progression.

Hemedan A, Satagopam V, Schneider R, Ostaszewski M iScience. 2024; 27(10):110956.

PMID: 39429779 PMC: 11489052. DOI: 10.1016/j.isci.2024.110956.

The role of microRNAs in pregnancies complicated by maternal diabetes.

Owen M, Kennedy M, Quilang R, Scott E, Forbes K Clin Sci (Lond). 2024; 138(18):1179-1207.

PMID: 39289953 PMC: 11409017. DOI: 10.1042/CS20230681.

Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis.

Lin H, Chen X, Wang L, Zhu T, Feng X, Liu X Arch Gynecol Obstet. 2024; 310(2):1255-1264.

PMID: 38814453 PMC: 11258170. DOI: 10.1007/s00404-024-07518-x.

Epigenetic modifications of placenta in women with gestational diabetes mellitus and their offspring.

Yi Y, Wang T, Xu W, Zhang S World J Diabetes. 2024; 15(3):378-391.

PMID: 38591094 PMC: 10999040. DOI: 10.4239/wjd.v15.i3.378.

The implication of miR-200a and miR-132 expression and their correlations with NF-κB/TNF-alpha signaling in adults with diabetic nephropathy.

Negeem Z, Moneim A, Mahmoud B, Ahmed A, Abd El-Hameed A, Eskandrani A Saudi J Biol Sci. 2024; 31(5):103975.

PMID: 38544953 PMC: 10966293. DOI: 10.1016/j.sjbs.2024.103975.

References

Xiao J, Gao R, Bei Y, Zhou Q, Zhou Y, Zhang H . Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure. Cell Physiol Biochem. 2017; 41(3):865-874. PMC: 5509048. DOI: 10.1159/000459899. View

Zhang H, Liu A, Feng X, Tian L, Bo W, Wang H . MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol. 2017; 148:65-72. DOI: 10.1016/j.pbiomolbio.2017.09.019. View

Spaight C, Gross J, Horsch A, Puder J . Gestational Diabetes Mellitus. Endocr Dev. 2016; 31:163-78. DOI: 10.1159/000439413. View

Wang H, Wang W, Zhuang H, Xu M . MiR-429 regulates the proliferation and apoptosis of nephroblastoma cells through targeting c-myc. Eur Rev Med Pharmacol Sci. 2018; 22(16):5172-5179. DOI: 10.26355/eurrev_201808_15713. View

Zhao C, Dong J, Jiang T, Shi Z, Yu B, Zhu Y . Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One. 2011; 6(8):e23925. PMC: 3161072. DOI: 10.1371/journal.pone.0023925. View

Miao M, Dai M, Zhang Y, Sun F, Guo X, Sun G . Influence of maternal overweight, obesity and gestational weight gain on the perinatal outcomes in women with gestational diabetes mellitus. Sci Rep. 2017; 7(1):305. PMC: 5428436. DOI: 10.1038/s41598-017-00441-z. View

Muralimanoharan S, Maloyan A, Myatt L . Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: role of miR-143. Clin Sci (Lond). 2016; 130(11):931-41. PMC: 4918818. DOI: 10.1042/CS20160076. View

Tian F, Qin C, Li X, Wu F, Liu X, Xu W . Decreased stathmin-1 expression inhibits trophoblast proliferation and invasion and is associated with recurrent miscarriage. Am J Pathol. 2015; 185(10):2709-21. DOI: 10.1016/j.ajpath.2015.06.010. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011; 35 Suppl 1:S64-71. PMC: 3632174. DOI: 10.2337/dc12-s064. View

10.

Zong S, Li C, Luo C, Zhao X, Liu C, Wang K . Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration. Sci Rep. 2016; 6:19916. PMC: 4728682. DOI: 10.1038/srep19916. View

11.

Cao J, Zhang L, Li J, Tian S, Lv X, Wang X . Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus. Sci Rep. 2016; 6:32268. PMC: 5004196. DOI: 10.1038/srep32268. View

12.

Xiao J, Tao T, Yin Y, Zhao L, Yang L, Hu L . miR-144 may regulate the proliferation, migration and invasion of trophoblastic cells through targeting PTEN in preeclampsia. Biomed Pharmacother. 2017; 94:341-353. DOI: 10.1016/j.biopha.2017.07.130. View

13.

Kaiser J . Reproductive biology. Gearing up for a closer look at the human placenta. Science. 2014; 344(6188):1073. DOI: 10.1126/science.344.6188.1073. View

14.

Qiu Z, Li H, Wang J, Sun C . miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma. Oncol Rep. 2017; 38(5):2735-2740. PMC: 5780026. DOI: 10.3892/or.2017.5994. View

15.

Wan S, Wang J, Wang J, Wu J, Song J, Zhang C . Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes Res Clin Pract. 2017; 130:171-179. DOI: 10.1016/j.diabres.2017.06.005. View

16.

Peng H, Li H, Li M . High glucose induces dysfunction of human umbilical vein endothelial cells by upregulating miR-137 in gestational diabetes mellitus. Microvasc Res. 2018; 118:90-100. DOI: 10.1016/j.mvr.2018.03.002. View

17.

Wang S, Li Y, Jiang Y, Li R . Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2017; 21(18):4092-4097. View

18.

Li Y, Xiao R, Li C, Huangfu J, Mao J . Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit. 2015; 21:426-31. PMC: 4329941. DOI: 10.12659/MSM.892431. View

19.

Xue L, Nan J, Dong L, Zhang C, Li H, Na R . Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma. Cancer Biomark. 2017; 19(2):193-197. DOI: 10.3233/CBM-160506. View

20.

Vishnoi A, Rani S . MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol. 2016; 1509:1-10. DOI: 10.1007/978-1-4939-6524-3_1. View